Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT01831505
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or over
* Has enlarged lymph node(s) highly suspicious of lymphoma; or has been diagnosed with lymphoma but is untreated; or has persistent recurrent, or progressive lymphoma
* At least one enlarged lymph node that is considered accessible for percutaneous injection by the investigator and that is at least 2 cm in longest dimension.
* ECOG performance status of 0-2 (or a Karnofsky performance status of \>50%).
* Labs required for enrollment: Absolute neutrophil count \> 1000/mm3, platelet count \> 50,000/mm3, hematocrit \> 25%, creatinine \<3.0 mg/dl, total bilirubin \<4.0 mg/dl, SGOT and SGPT less than five times the institutional upper limits of normal.
Exclusion Criteria:
* Lymphoma patients in which the delay of surgery until the lymph node resection date or other factors associated with the study are not feasible.
* Patients with central nervous system disease.
* Any therapy that is potentially immunosuppressive or has anticancer activity in the 4 weeks prior to device microinjection.
* Patients with active fungal, viral, or bacterial infections
* Pregnant women.
* Inability to give informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01831505
Study Brief:
Protocol Section:
NCT01831505